HomeCompareFSK vs ECL

FSK vs ECL: Dividend Comparison 2026

FSK yields 18.89% · ECL yields 1.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSK wins by $46.9K in total portfolio value
10 years
FSK
FSK
● Live price
18.89%
Share price
$9.95
Annual div
$1.88
5Y div CAGR
2.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.7K
Annual income
$8,463.51
Full FSK calculator →
ECL
ECL
● Live price
1.05%
Share price
$262.49
Annual div
$2.76
5Y div CAGR
36.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.8K
Annual income
$3,316.22
Full ECL calculator →

Portfolio growth — FSK vs ECL

📍 FSK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSKECL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSK + ECL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSK pays
ECL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSK
Annual income on $10K today (after 15% tax)
$1,606.03/yr
After 10yr DRIP, annual income (after tax)
$7,193.98/yr
ECL
Annual income on $10K today (after 15% tax)
$89.37/yr
After 10yr DRIP, annual income (after tax)
$2,818.79/yr
At 15% tax rate, FSK beats the other by $4,375.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSK + ECL for your $10,000?

FSK: 50%ECL: 50%
100% ECL50/50100% FSK
Portfolio after 10yr
$55.2K
Annual income
$5,889.86/yr
Blended yield
10.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ECL right now

FSK
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$15.00
+50.8% upside vs current
Range: $15.00 — $15.00
Altman Z
-0.0
Piotroski
3/9
ECL
Analyst Ratings
26
Buy
10
Hold
1
Sell
Consensus: Buy
Price Target
$326.30
+24.3% upside vs current
Range: $300.00 — $345.00
Altman Z
4.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSK buys
0
ECL buys
0
No recent congressional trades found for FSK or ECL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSKECL
Forward yield18.89%1.05%
Annual dividend / share$1.88$2.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR2.3%36.1%
Portfolio after 10y$78.7K$31.8K
Annual income after 10y$8,463.51$3,316.22
Total dividends collected$46.6K$10.4K
Payment frequencyquarterlyquarterly
SectorBDCMaterials
Analyst consensusHoldBuy
Analyst price target$15.00$326.30

Year-by-year: FSK vs ECL ($10,000, DRIP)

YearFSK PortfolioFSK Income/yrECL PortfolioECL Income/yrGap
1← crossover$12,633$1,932.90$10,843$143.10+$1.8KFSK
2$15,852$2,334.56$11,799$197.37+$4.1KFSK
3$19,762$2,800.73$12,899$273.19+$6.9KFSK
4$24,484$3,338.26$14,181$379.86+$10.3KFSK
5$30,152$3,954.17$15,705$531.22+$14.4KFSK
6$36,918$4,655.67$17,553$748.30+$19.4KFSK
7$44,952$5,450.05$19,845$1,063.78+$25.1KFSK
8$54,444$6,344.63$22,764$1,529.81+$31.7KFSK
9$65,601$7,346.71$26,590$2,232.07+$39.0KFSK
10$78,657$8,463.51$31,768$3,316.22+$46.9KFSK

FSK vs ECL: Complete Analysis 2026

FSKBDC

FS KKR Capital Corp. is a business development company specializing in investments in debt securities. It provides customized credit solutions to private middle market U.S. companies. It invest primarily in the senior secured debt and, to a lesser extent, the subordinated debt of private middle market U.S. companies. It seeks to purchase interests in loans through secondary market transactions or directly from the target companies as primary market investments. It also seeks to invest in first lien senior secured loans, second lien secured loans and, to a lesser extent, subordinated loans, or mezzanine loans. In connection with the debt investments, the firm also receives equity interests such as warrants or options as additional consideration. It also seek to purchase minority interests in the form of common or preferred equity in our target companies, either in conjunction with one of the debt investments or through a co-investment with a financial sponsor. Additionally, on an opportunistic basis, the fund may also invest in corporate bonds and similar debt securities. The fund does not seek to invest in start-up companies, turnaround situations, or companies with speculative business plans. It seeks to invest in small and middle-market companies based in United States. The fund seeks to invest in firms with annual revenue between $10 million to $2.5 billion. It focus on providing customized one-stop credit solutions to private upper middle market companies with annual EBITDA of $50 million to $100 million at the time of investment. It seeks to exit from securities by selling them in a privately negotiated over- the- counter market. For any investments that are not able to be sold within the secondary market, the firm seeks to exit such investments through repayment, an initial public offering of equity securities, merger, sale or recapitalization.

Full FSK Calculator →

ECLMaterials

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Full ECL Calculator →
📬

Get this FSK vs ECL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSK vs SCHDFSK vs JEPIFSK vs OFSK vs KOFSK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.